Animal Vaccines Market to Generate $15.20 Billion, By 2030 at 5.2% CAGR: Allied Market Research
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/1988
Drivers, Restraints, and Opportunities
Increase in demand for pet insurance, surge in prevalence of animal diseases, rise in expenditure for animal health, and increase in ownership of companion animals propel the global animal vaccines market growth. However, highly competitive meat and milk prices and fatal effects of veterinary vaccines on human and animal health restrain the market growth. Contrarily, advancements in vaccine products and increase in demand for hybrid animal present new opportunities in coming years.
Covid-19 Scenario
- The Covid-19 pandemic impacted the animal vaccine market negatively. The veterinary organizations recommended restraints on animal patient care and postponed the surgery of animals with mild illnesses. However, surgeries and vaccination procedures of acutely ill animals were carried out.
- The lockdown measures led to postponement of annual checkups and elective vaccination processes. However, the supply of animal vaccines led to disruptions due to challenges in supply chain.
The attenuated vaccines segment to continue its lead position during the forecast period
Based on product, the attenuated vaccines segment accounted for the largest market share in 2020, contributing to nearly two-fifths of the global animal vaccines market, and is estimated to maintain its lead position by 2030. This is due to presence of advanced technologies for specific mutations/deletions in the virus genes. However, the DNA vaccines segment is expected to register the fastest CAGR of 8.1% during the forecast period, owing to surge in prevalence of animal diseases and ease in manipulation in comparison to traditional vaccines.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/1988
The livestock segment to continue its leadership status in terms of revenue by 2030
Based on animal type, the livestock animal segment held nearly than two-thirds of the global animal vaccines market in 2020, and is expected to maintain its leadership status based in terms of revenue by 2030. This is attributed to increase in the prevalence of infectious diseases among livestock animals and rise in awareness about immunization. However, the companion animal segment is projected to portray the largest CAGR of 5.5% during the forecast period, owing to rise in awareness regarding medical illnesses & ailments of companion animals and surge in animal healthcare expenditure worldwide.
Based on region,
Leading Market Players
- Merck & Co., Inc.
- Zoetis Inc.
- Ceva Santé Animale
Sanofi S.A. - Romvac
- Vaxxinova
- Biovac
- Merial
Boehringer Ingelheim GmbH Anicon Labor GmbH
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Small Animal Imaging (In-Vivo)
Veterinary Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Veterinary Medicine Market - Global Opportunity Analysis and Industry Forecast, 2020-2030
Veterinary Pain Management Market - Global Opportunity Analysis and Industry Forecast, 2020–2030
About Us
Contact:
#205,
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/
View original content:https://www.prnewswire.com/news-releases/animal-vaccines-market-to-generate-15-20-billion-by-2030-at-5-2-cagr-allied-market-research-301465554.html
SOURCE
2022 Medicare Supplement Price Index Released by AAMSI
– Reed Smith Adds Nicholas Insua as Insurance Recovery Group Partner in Princeton, New York
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News